SUPPLEMENTARY INFORMATION:

In the Federal Register of March 23, 2026, 91 FR 13849, FDA announced that a public hearing related to the CNPV Pilot Program would be held on June 12, 2026. On page 13849, in the third column, the DATES portion of the document is changed to read as follows:

• The public hearing will be held with an in-person and virtual option (i.e., hybrid) on June 4, 2026, from 1:00 p.m. to 4:00 p.m. Eastern Time. Meeting registration, including requests for participation in the public hearing, can be found at the following website: https://www.fda.gov/​news-events/​fda-meetings-conferences-and-workshops/​commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026. All requests for participation, including those who wish to present during the public hearing, must be received by April 24, 2026, through the meeting registration page. Questions about meeting registration and participation should be sent to CNPVPublicMeeting@fda.hhs.gov and include the title of this notice: “Commissioner's National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments”).

On page 13850, in the first column, the second and third paragraphs of the ADDRESSES portion of the document are changed to read as follows:

• Additional details, such as any changes to the time of the public hearing and registration information, will be posted athttps://www.fda.gov/​news-events/​fda-meetings-conferences-and-workshops/​commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026. The online web conference meeting link can be accessed at https://www.fda.gov/​news-events/​fda-meetings-conferences-and-workshops/​commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026 on the day of the meeting.
• All written requests for participation in the pilot program must be received by April 24, 2026 (email to:CNPVPublicMeeting@fda.hhs.gov).

On page 13850, in the third column, the FOR FURTHER INFORMATION CONTACT portion of the document is changed to read as follows:

• Mallika Mundkur, Deputy Chief Medical Officer, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-8800,CNPVPublicMeeting@fda.hhs.gov.

On page 13852, in the second column, the IV. Participating in Public Hearing portion of the SUPPLEMENTARY INFORMATION section is changed to read as follows:

• Registration: To register to attend or participate in the free public hearing, please visit the following website: https://www.fda.gov/​news-events/​fda-meetings-conferences-and-workshops/​commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026.
• Written Notice of Participation: All written requests for participation must be received by April 24, 2026, 11:59 p.m. Eastern Time (email to: CNPVPublicMeeting@fda.hhs.gov).
• Transcripts: A link to the transcript will also be available on the internet at https://www.fda.gov/​news-events/​fda-meetings-conferences-and-workshops/​commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026.

91 FR 21822